Evaluation of Adhesion Properties in Wound Care Devices
Launched by MOLNLYCKE HEALTH CARE AB · Apr 26, 2024
Trial Information
Current as of August 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Evaluation of Adhesion Properties in Wound Care Devices," is designed to study how well self-adhesive wound care products stick to the skin. These devices, made by Molnlycke, are used to protect different types of wounds during healing. Since there isn't a lab test that can accurately mimic how these devices adhere to human skin, the trial will involve placing special test strips on participants' skin for a certain period. After removing the strips, the researchers will assess how well they stuck.
If you're considering participating, you must be between the ages of 65 and 74 or 24 to 47 years old and agree to join the study by signing a consent form. However, individuals with known allergies to adhesive materials or who are pregnant or breastfeeding cannot participate. This study is not yet recruiting participants, but it aims to provide important information about how these wound care devices work in real-life situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed eligibility and signed consent form.
- Exclusion Criteria:
- • Known plaster allergy or other known contact hypersensitivity
- • Pregnant or breastfeeding individual.
About Molnlycke Health Care Ab
Mölnlycke Health Care AB is a global medical solutions company specializing in the development and manufacturing of innovative wound care and surgical products. With a strong commitment to enhancing patient outcomes, Mölnlycke combines extensive clinical expertise with advanced technology to deliver high-quality medical devices and solutions. The company operates with a focus on sustainability and collaboration with healthcare professionals, ensuring that their products meet the evolving needs of patients and healthcare systems worldwide. Through rigorous clinical trials and research, Mölnlycke continues to advance the field of healthcare, aiming to improve healing processes and promote patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gothenburg, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported